Relmada Therapeutics Inc (RLMD) - Pendapatan lan volume dodolan
Reviewing the quarterly sales of Relmada Therapeutics (RLMD) on GURU.Markets, we observe that the value remains at 0.00. Relmada Therapeutics (RLMD) development is based on the automated synthesis of substances, although patient control remains with physicians. The massive potential of the antidepressant market promises colossal demand following approval. The asset's ultimate success relies on the safety of REL-1017 and the absence of side effects in the final phase of testing.
Rincian metrik komprehensif lan analitis Relmada Therapeutics, Inc. (RLMD)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
- rincian nilai buku perusahaan:
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Relmada Therapeutics|RLMD - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Relmada Therapeutics Inc|RLMD - Utang perusahaan|Rasio utang marang aset resik Relmada Therapeutics, Inc.|RLMD - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Relmada Therapeutics|Rasio likuiditas kritis relmada.com
- indikator bathi lan kelipatan valuasi:
RLMD - Bathi resik|Bathi resik sing dikarepake Relmada Therapeutics|RLMD - Koefisien rega marang bathi|Pangali Forward P/E relmada.com|RLMD - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Relmada Therapeutics, Inc.|RLMD - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Relmada Therapeutics|RLMD - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan relmada.com|RLMD - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Relmada Therapeutics
- rincian pendapatan lan dodolan emiten:
Analisis komprehensif perusahaan:Relmada Corp - RLMD
Investors are assessing fundamental risks through the lens of actual operational activity rather than static reports. For Relmada Therapeutics (RLMD), the results of Phase 3 antidepressant trials are critical, as they determine the future value of the business. This sales data series for the company captures daily revenue inflows, excluding GAAP accounting delays. The stability of this flow allows for the differentiation of speculative noise from sustainable commercial development.
Pesaing wigati
Volume dodolan perusahaan BIIB (Biogen Idec)|Pendapatan lan volume dodolan NBIX|Pendapatan lan volume dodolan regencellbioscience.com (RGC)|Axsome Therapeutics, Inc. - Dodolan perusahaan|Pendapatan dodolan perusahaan ACAD|XENE: Dodolan perusahaan|Viking Therapeutics Corp - Total dodolan perusahaan|SUPN: Pendapatan lan volume dodolan|catalystpharma.com - Pendapatan dodolan perusahaan|DNLI (Denali Therapeutics Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Harmony Biosciences Inc HRMY|Pendapatan perusahaan Biohaven Pharmaceutical (BHVN)|AMLX (Amylyx Corp) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan TRVI (Trevi Therapeutics)|Pendapatan lan volume dodolan praxismedicines.com PRAX|AVXL - Pendapatan perusahaan|Pendapatan tahunan perusahaan CBLL|PRTA: Pendapatan lan volume dodolan|Total pendapatan perusahaan Alector (ALEC)|Dodolan perusahaan ANNX|Pendapatan lan volume dodolan Omeros Corp.|Dodolan perusahaan NGNE (Neurogene)|Total dodolan perusahaan ACIU|Pendapatan lan volume dodolan VYGR (Voyager Pharma)|Pendapatan reged perusahaan Neumora Corp (NMRA)|Scilex Holding Company - Pendapatan lan volume dodolan|tevogen.com (TVGN) - Dodolan perusahaan|alphacognition.com (ACOG) - Pendapatan perusahaan|CGTX - Pendapatan reged perusahaan|Pendapatan perusahaan Inhibikase|SAVA: Pendapatan dodolan perusahaan|Pendapatan perusahaan Assertio Holdings, Inc. (ASRT)|Pendapatan perusahaan COYA (coyatherapeutics.com)|Pendapatan perusahaan Vistagen VTGN|OVID - Dodolan perusahaan|Acumen Pharma - Pendapatan lan volume dodolan|CRVO (CervoMed Corporation) - Volume dodolan perusahaan|alteritytherapeutics.com (ATHE) - Pendapatan perusahaan|Volume dodolan perusahaan CLNN|PEPG (PepGen Inc) - Pendapatan lan volume dodolan|Total pendapatan perusahaan jupiterneurosciences.com JUNS|Dodolan perusahaan ANVS (Annovis Bio Corp)|Pendapatan lan volume dodolan gracetx.com (GRCE)|Pendapatan perusahaan Firefly Neuroscience, Inc AIFF|Pendapatan dodolan perusahaan KLTO|NRSN - Pendapatan perusahaan|Total pendapatan perusahaan Reviva Pharmaceuticals Holdings Inc.|metaviatx.com (MTVA) - Pendapatan perusahaan|NeurAxis Inc - Pendapatan dodolan perusahaan|HSDT (Helius Medical Technologies, Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Passage Bio Corp PASG|Pendapatan perusahaan Neuphoria Therapeutics Inc. (NEUP)|Pendapatan perusahaan NERV (Minerva Neurosciences Inc)|Pendapatan perusahaan Athira ATHA|ADXN - Dodolan perusahaan|Alzamend - Pendapatan lan volume dodolan|CYCN - Pendapatan lan volume dodolan|PTIX: Pendapatan lan volume dodolan|Volume dodolan perusahaan KTTA|CRGT (Cortigent Inc) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Avenue Therapeutics Inc|Dodolan perusahaan BCLI (Brainstorm Cell)|CARA (caratherapeutics.com) - Pendapatan dodolan perusahaan|Chromocell Therapeutics Corp. - Dodolan perusahaan|Total dodolan perusahaan ELYM (Eliem Therapeutics, Inc.)|Intra-Cellular - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan LBPH (Longboard)|MRNS: Pendapatan lan volume dodolan|Total pendapatan perusahaan nkgenbiotech.com (NKGN)|Pendapatan perusahaan NeuroBo Pharmaceuticals, Inc.|SAGE: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan SNPX|Pendapatan lan volume dodolan Trevena Inc (TRVN)|Pendapatan perusahaan Vigil Neuroscience, Inc. VIGL|WENA (Anew Medical Inc.) - Pendapatan tahunan perusahaan|Cerevel Therapeutics, Inc. - Pendapatan lan volume dodolan
